| Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice A Shahangian, EK Chow, X Tian, JR Kang, A Ghaffari, SY Liu, JA Belperio, ... The Journal of clinical investigation 119 (7), 1910-1920, 2009 | 569 | 2009 |
| DDX1, DDX21, and DHX36 helicases form a complex with the adaptor molecule TRIF to sense dsRNA in dendritic cells Z Zhang, T Kim, M Bao, V Facchinetti, SY Jung, AA Ghaffari, J Qin, ... Immunity 34 (6), 866-878, 2011 | 403 | 2011 |
| Lipopolysaccharide-mediated IL-10 transcriptional regulation requires sequential induction of type I IFNs and IL-27 in macrophages SS Iyer, AA Ghaffari, G Cheng The Journal of Immunology 185 (11), 6599-6607, 2010 | 238 | 2010 |
| ASC/caspase‐1/IL‐1β signaling triggers inflammatory responses by promoting HMGB1 induction in liver ischemia/reperfusion injury N Kamo, B Ke, AA Ghaffari, X Shen, RW Busuttil, G Cheng, ... Hepatology 58 (1), 351-362, 2013 | 189 | 2013 |
| Poly I: C enhances susceptibility to secondary pulmonary infections by gram-positive bacteria X Tian, F Xu, WY Lung, C Meyerson, AA Ghaffari, G Cheng, JC Deng Public Library of Science 7 (9), e41879, 2012 | 88 | 2012 |
| Testosterone treatment increases thromboxane function in rat cerebral arteries RJ Gonzales, AA Ghaffari, SP Duckles, DN Krause American Journal of Physiology-Heart and Circulatory Physiology 289 (2 …, 2005 | 86 | 2005 |
| A TRAF3-NIK module differentially regulates DNA vs RNA pathways in innate immune signaling K Parvatiyar, J Pindado, A Dev, SR Aliyari, SA Zaver, H Gerami, ... Nature communications 9 (1), 2770, 2018 | 37 | 2018 |
| Suppressing fatty acid synthase by type I interferon and chemical inhibitors as a broad spectrum anti-viral strategy against SARS-CoV-2 SR Aliyari, AA Ghaffari, O Pernet, K Parvatiyar, Y Wang, H Gerami, ... Acta Pharmaceutica Sinica B 12 (4), 1624-1635, 2022 | 15 | 2022 |
| Polyinosinic‐polycytidylic acid suppresses acetaminophen‐induced hepatotoxicity independent of type I interferons and toll‐like receptor 3 AA Ghaffari, EK Chow, SS Iyer, JC Deng, G Cheng Hepatology 53 (6), 2042-2052, 2011 | 13 | 2011 |
| Cellular Signaling Analysis shows antiviral, ribavirin-mediated ribosomal signaling modulation X Ding, PO Krutzik, AA Ghaffari, Y Zhaozhi, D Miranda Jr, G Cheng, ... Antiviral Research 171, 104598, 2019 | 5 | 2019 |
| Nightshade Vegetables: A Dietary Trigger for Worsening Inflammatory Bowel Disease and Irritable Bowel Syndrome? R Kuang, DJ Levinthal, AA Ghaffari, CR Del Aguila de Rivers, A Tansel, ... Digestive Diseases and Sciences 68 (7), 2853-2860, 2023 | 3 | 2023 |
| Suppressing fatty acid synthase by type Ⅰ interferon and chemical inhibitors as a broad spectrum anti-viral strategy against SARS-CoV-2 SR Aliyari, AA Ghaffari, O Pernet, K Parvatiyar, Y Wang, H Gerami, ... 药学学报: 英文版 12, 12, 2022 | 1 | 2022 |
| Su507 INCREASED HOSPITAL ADMISSIONS ARE ASSOCIATED WITH DECREASED GUT MICROBIOME DIVERSITY AND DECREASED FAECALOBACTERIUM IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A … AA Ghaffari, F Koutroumpakis, CR Rivers, K Li, M Ahsan, A Wilson, ... Gastroenterology 160 (6), S-720, 2021 | 1 | 2021 |
| Fr554 DISPARITIES IN TREATMENT AND HEALTHCARE UTILIZATION BEETWEEN INFLAMMATORY BOWEL DISEASE PATIENTS FOLLOWED AT A REFERRAL UNIVERSITY CENTER AND COMMUNITY HOSPITALS F Koutroumpakis, AA Ghaffari, M Ahsan, CR Rivers, Z Alkaissy, A Barrie, ... Gastroenterology 160 (6), S-360, 2021 | 1 | 2021 |
| S3177 Oral Vancomycin Therapy for the Treatment of PSC-Related IBD Colitis and Pouchitis G Kaya, J Sleiman, AA Ghaffari, JM Dueker Official journal of the American College of Gastroenterology| ACG 118 (10S …, 2023 | | 2023 |
| Sa1821 PREVALENCE AND RISK FACTORS OF EXOCRINE PANCREATIC INSUFFICIENCY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE C Traboulsi, CR Rivers, AA Ghaffari, E Johnston, J Dueker, M Schwartz, ... Gastroenterology 164 (6), S-447, 2023 | | 2023 |
| Mo1808 THE EFFECTS OF ILEOCECAL RESECTION ON FECAL MICROBIOME DIVERSITY AND COMPOSITION ARE NOT SIGNIFICANTLY ALTERED BY BILE ACID SEQUESTRANTS IN PATIENTS WITH CROHN'S DISEASE AA Ghaffari, K Li, CR Rivers, E Johnston, J Dueker, M Schwartz, B Methe, ... Gastroenterology 164 (6), S-919, 2023 | | 2023 |
| 1138: ULTRA-PROCESSED FOOD CONSUMPTION AND MULTIYEAR CLINICAL TRAJECTORIES IN IBD S Jacob, CR Rivers, AA Ghaffari, T Al Choufete, E Johnston, J Dueker, ... Gastroenterology 162 (7), S-266-S-267, 2022 | | 2022 |
| Mo1478: PARASTOMAL PYODERMA GANGRENOSUM IN IBD: PREVALENCE, TREATMENT, AND CLINICAL OUTCOMES IN A TERTIARY CENTER B Nguyen, CR Rivers, BM Patel, AA Ghaffari, E Johnston, J Dueker, ... Gastroenterology 162 (7), S-781-S-782, 2022 | | 2022 |
| Mo1538: BASELINE PERIPHERAL BLOOD EOSINOPHILIA PREDICTS DECREASED RESPONSE TO INITIAL ANTI-TNF BIOLOGIC THERAPY IN IBD F Koutroumpakis, CR Rivers, AA Ghaffari, E Gkiaouraki, E Johnston, ... Gastroenterology 162 (7), S-808-S-809, 2022 | | 2022 |
